Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥436.6bn2023-04-01 → 2023-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥228.9bn2023-07-01 → 2023-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥417.1bn2022-04-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥224.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS (5-year summary)
Operating income¥4.8bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥17.7bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥93.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥49.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax−¥958m2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥20.7bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥89.3bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥216.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥24.3bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥66.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥216.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥24.0bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥66.9bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥1.62Tat 2023-09-30Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.49Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥790.2bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥867.1bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥827.5bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥644.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥827.5bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥643.0bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥488.2bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥297.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥11.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥412.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥15.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥125.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥35.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥173.812023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-19.642023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥52.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.972022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥173.432023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-19.62023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥52.452022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.932022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio51.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥18.6bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30¥50.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥28.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥23.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥4.3bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥68.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-09-30−¥788m
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.8bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥97.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 781
ItemContextValueUnit
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant205512000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1266178700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1266178700
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1266178700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1266178700
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember234679800
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1921
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember93046500
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0762
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember39936544
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0327
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember39509300
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0323
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember25675632
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0210
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember22811112
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0187
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember21258572
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0174
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember19788948
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0162
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember16813401
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0138
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember14738453
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0121
Number of shares heldCurrentQuarterInstant528258262
Shareholding ratioCurrentQuarterInstant0.4325
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember44638700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1221326400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember12213264
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember213600
Number of shares issued shares voting rightsCurrentQuarterInstant1266178700
Number of voting rights issued shares voting rightsCurrentQuarterInstant12213264
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member44638700
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member44638700
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0353
Number of shares held in own name treasury shares etcCurrentQuarterInstant44638700
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant44638700
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0353
Cash and cash equivalents IFRSPrior1YearInstant169329000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant488160000000JPY
Trade and other receivables ca IFRSPrior1YearInstant174672000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant171001000000JPY
Other financial assets ca IFRSPrior1YearInstant11360000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass